Most frequently reported treatment-emergent adverse events
| Adverse event . | Acarbose . | Placebo . |
|---|---|---|
| n | 40 | 43 |
| Flatulence | 57.5* | 27.9 |
| Diarrhea | 15.0 | 14.0 |
| Abdominal pain | 10.0 | 7.0 |
| Enlarged abdomen | 7.5 | 4.7 |
| Nausea | 5.0 | 2.3 |
| Chest pain | 5.0 | 2.3 |
| Dyspnea | 5.0 | 0.0 |
| Constipation | 2.5 | 7.0 |
| Any | 75.0 | 55.8 |
| Adverse event . | Acarbose . | Placebo . |
|---|---|---|
| n | 40 | 43 |
| Flatulence | 57.5* | 27.9 |
| Diarrhea | 15.0 | 14.0 |
| Abdominal pain | 10.0 | 7.0 |
| Enlarged abdomen | 7.5 | 4.7 |
| Nausea | 5.0 | 2.3 |
| Chest pain | 5.0 | 2.3 |
| Dyspnea | 5.0 | 0.0 |
| Constipation | 2.5 | 7.0 |
| Any | 75.0 | 55.8 |
Data are %. Possible or probable relation to study medication given.
P = 0.0064 vs. placebo.